ArticleAnnals of surgical oncology2023

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.

Xiao-Dong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.